Ting Kang
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 3
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 4
- Bone Tissue Engineering Materials 3
-
- Protein Degradation and Inhibitors 3
- Signaling Pathways in Disease 3
- Histone Deacetylase Inhibitors Research 3
-
- Orthopaedic implants and arthroplasty 3
-
- Alzheimer's disease research and treatments 3
In The Last Decade
Ting Kang
24 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Biomaterials 405
- Biomedical Engineering 558
- Cancer Research 153
- Molecular Biology 573
- Immunology 162
Countries citing papers authored by Ting Kang
This map shows the geographic impact of Ting Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Kang more than expected).
Fields of papers citing papers by Ting Kang
This network shows the impact of papers produced by Ting Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Kang. The network helps show where Ting Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ting Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 7 | |
| 5 | 2019 | 25 | |
| 6 | 2019 | 11 | |
| 7 | 2018 | 36 | |
| 8 | 2018 | 19 | |
| 9 | 2018 | 20 | |
| 10 | 2017 | 73 | |
| 11 | 2017 | 23 | |
| 12 | 2017 | 33 | |
| 13 | 2017 | 18 | |
| 14 | 2016 | 74 | |
| 15 | 2016 | 67 | |
| 16 | 2015 | 2 | |
| 17 | 2015 | 38 | |
| 18 | 2015 | 31 | |
| 19 | 2015 | 14 | |
| 20 | 2014 | 178 |
About Ting Kang
Ting Kang is a scholar working on Biomaterials, Oncology and Hematology, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Orthopaedic implants and arthroplasty (3 papers), Bone Tissue Engineering Materials (3 papers), Alzheimer's disease research and treatments (3 papers), Protein Degradation and Inhibitors (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Signaling Pathways in Disease (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Biomaterials (405 citations), Biomedical Engineering (558 citations) and Cancer Research (153 citations). Ting Kang has collaborated with scholars based in China and Canada. Frequent co-authors include Xiaoling Gao, Jun Chen, Hongzhuan Chen, Qingxiang Song, Jingxian Feng, Xunbin Wei, Tianze Jiang, Dan Wei, Xuebiao Yao and Qianqian Zhu. Their work appears in journals such as Journal of Clinical Oncology, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.